Kaitlyn D’Onofrio

DocwireNews

A study questioned which is the best strategy to employ in <a href="https://www.docwirenews.com/rheumatology/recovery-rate-and-length-of-stay-but-not-therapy-time-affect-discharge-position-following-hip-fracture-surgery/">traumatic</a> finger amputations and concluded that the target technique will depend on the <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/craniosacral-therapy-effectively-treats-chronic-pain/">patient</a>.Each year, more than 45,000 patients in the U.S. undergo <a href="https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/perfect-anatomic-alignment-in-distal-radius-fractures-does-not-mean-better-patient-outcomes/">traumatic finger amputations</a>, which require a multifaceted recovery plan that encompasses building strength, flexibility, and sensation, and managing not only physical outcomes but psychological ones as well.&ldquo;The decision for surgical treatment for traumatic finger amputation is made on a case-by-case basis and typically includes replantation or primary closure of the amputated stump (revision amputation). Although there are de facto indications that guide the surgeon&rsquo;s decision of replantation or revision amputation, to date, there are no formal clinical practice guidelines available to the surgeon,&rdquo; the study authors explained.The researchers reviewed data from a retrospective cohort study who underwent revision amputation or replantation at 19 U.S.- and Asia-based centers between Aug. 1, 2016, and April 12, 2018. The present analysis included data on 185 patients. The primary outcomes were hand strength, dexterity, hand-related quality of life, and pain, and the study authors employed a tree-based statistical learning method to obtain clinical decision rules for traumatic finger amputation treatment.The results appeared in <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2761548">JAMA Network Open</a>.The patients in the present study had a mean age (SD) age of 45 (16) years, and the majority of the population (n=156, 84%) was male. Each patient had a median one finger (range, one to five) amputated. Most amputations (n=115, 62%) were distal to the proximal interphalangeal joint; the majority of surgeries (n=110, 60%) were in the nondominant hand.Implementation of the tree-based statistical learning estimates found that different strategies were associated with different outcomes. Maximal hand dexterity or minimal patient-reported pain was obtained through replantation. Maximal hand strength was obtained through revision amputation in the case of a single-finger amputation; in all other cases, replantation was the best approach. Maximal patient-reported quality of life was obtained through revision amputation in patients with dominant hand injuries, and replantation was favorable in the case of nondominant hand injuries.&ldquo;In this analysis, we described an evidence-based clinical decision support tool that may be able to assist surgeons in making personalized treatment decisions for patients with traumatic finger amputation. The findings suggest that there is no prescribed approach to treating traumatic finger amputations,&rdquo; concluded the researchers. &ldquo;We demonstrated the application of statistical learning techniques to supplement standard statistical analyses and to provide data-driven, evidence-based solutions for an important clinical condition.&rdquo;

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

The Optimal Avenue for Traumatic Finger Amputation Varies by Patient

Orthopedics

A study questioned which is the best strategy to employ in traumatic finger amputations and concluded that the target technique will depend on the patient. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe